Concepedia

Publication | Open Access

Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma

37

Citations

10

References

2020

Year

Abstract

PRI-724(C-82) may be a novel drug for β-catenin-activated HCC therapy.

References

YearCitations

Page 1